These results showed that overexpression of Mel-18, or knockdown of BMI1 reduces malignancy of both p16 positive and p16-negative gastric cancer cell lines, suggesting that the mechanism of reduction in malignancy by BMI1 downregulation is at least in part independent of p16 pathway. This evidence concerns the gene CDKN2A and gastric cancer.